Preeclamptic serum and soluble fms-like tyrosine kinase-1 suppress endothelial inward rectifier potassium currents

This publication has 55 references indexed in Scilit:

• Hydrogen Sulfide as Endothelium-Derived Hyperpolarizing Factor Sulfhydrates Potassium Channels
  Circulation Research, 2011
• Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis
  Vascular Cell, 2011
• Endothelium-Derived Hyperpolarizing Factor and Vascular Function
  Cardiology Research and Practice, 2011
• Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension: Basics for Primary Care Providers
  Cardiology Research and Practice, 2011
• The Soluble VEGF Receptor sFlt1 Contributes to Endothelial Dysfunction in CKD
  Journal of the American Society of Nephrology, 2009
• A Recently Evolved Novel Trophoblast-Enriched Secreted Form of fms-Like Tyrosine Kinase-1 Variant Is Up-Regulated in Hypoxia and Preeclampsia
  The Journal of Clinical Endocrinology & Metabolism, 2009
• Nitric Oxide Formation Is Inversely Related to Serum Levels of Antiangiogenic Factors Soluble Fms-Like Tyrosine Kinase-1 and Soluble Endogline in Preeclampsia
  Hypertension, 2008
• Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction
  American Journal of Physiology-Heart and Circulatory Physiology, 2008
• Endothelial Dysfunction
  Hypertension, 2007
• Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop
  American Journal of Obstetrics and Gynecology, 2004